ABT-493/ABT-530
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for ABT-493/ABT-530, covering 2017-09-14 to 2019-02-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection [Phase 3]